Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors

A legfontosabb adatok

Ki végzi
M.D. Anderson Cancer Center
Hol
Houston (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Leállítva
Résztvevők
3 fő vett részt
Kezdés
2022. nov. 17.
Befejezés
2025. nov. 5.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • Simulated Online Adaptive Planning
  • Stereotactic MRI-guided adaptive radiotherapy-SMART
A regiszteradat frissítve
2025. november 10.
Miért állt le
\<75 % participation

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 16 feltétel megnézéseKevesebb

Ki vehet részt

  • Primary lung cancer or lung metastasis from another primary
  • Central tumors ≤ 2 cm from any mediastinal critical structure (proximal bronchial tree, esophagus, heart, brachial plexus, major vessels, spinal cord, phrenic nerve, and recurrent laryngeal nerve
  • Age ≥ 18 years
  • Ability to understand and the willingness to sign a written informed consent
  • Primary lung cancer or lung metastasis from another primary
  • Central tumors ≤ 2 cm from any mediastinal critical structure (proximal bronchial tree, esophagus, heart, brachial plexus, major vessels, spinal cord, phrenic nerve, and recurrent laryngeal nerve
  • Age ≥ 18 years
  • Ability to understand and the willingness to sign a written informed consent
  • Determined by two thoracic radiation oncologists to require > 10-15 fraction regimens if treated with CT-based, non-adaptive radiation therapy

Ki nem vehet részt

  • Women who are pregnant. Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control, abstinence) prior to study entry. Should a woman become pregnant or suspect she is pregnant while participating in this study, she must inform her treating physician immediately; Stage 2:
  • Women who are pregnant. Women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control, abstinence) prior to study entry. Should a woman become pregnant or suspect she is pregnant while participating in this study, she must inform her treating physician immediately
  • Inability to tolerate MR imaging (Ie. history of claustrophobia)
  • Inability to tolerate MR imaging (Ie. history of claustrophobia)
  • Contraindications to MR imaging (e.g. implanted metallic prostheses, defibrillators, stimulators, pacemakers, or neurotransmitters) per institutional policy on management of patients with internal and external medical devices
  • Contraindications to MR imaging (e.g. implanted metallic prostheses, defibrillators, stimulators, pacemakers, or neurotransmitters) per institutional policy on management of patients with internal and external medical devices

Egyéb feltételek

  • Stage I:

Helyszínek itt: Egyesült Államok

  • M D Anderson Cancer CenterHouston, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

To learn if using MRI (magnetic resonance imaging) to guide radiation therapy can help to control central lung cancer. The results of the MRI-guided radiation therapy will be compared to conventional radiation therapy (guided by CT scans) during this study.

A vizsgálat 2 csoportja

  • Stage I-(Simulated Online Adaptive Planning)A vizsgált kezelés

    Participants will receive treatment with the conventional CT-based radiation therapy and receive additional MRI scans.

    Kezelés: Simulated Online Adaptive Planning

  • Stage II (Stereotactic MRI-guided adaptive radiotherapy-SMART)A vizsgált kezelés

    Participants will receive treatment with the investigational MRI-guided radiation therapy.

    Kezelés: Stereotactic MRI-guided adaptive radiotherapy-SMART

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2025. november 10.